BioAge Labs, Inc.
For the period ended Dec 31, 2024. Filed Mar 20, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 20, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
We currently occupy approximately 18,829 square feet of office and laboratory space at our corporate headquarters in Richmond, California under a lease that expires in August 2025.
In September 2024, the Company executed a 72-month lease for 10,479 square feet of office and laboratory space located in Emeryville, California (the "Emeryville Lease"). The Emeryville Lease commenced in February 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.